US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 673.600
  • -0.670-0.10%
Close Feb 14 16:00 ET
  • 673.600
  • 0.0000.00%
Post 20:01 ET
73.64BMarket Cap17.57P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.78%4.42B
15.89%1.26B
15.88%1.29B
-65.38%354M
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
Net income from continuing operations
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
Operating gains losses
-144.41%-118.3M
466.44%212.9M
-206.06%-134.7M
-1,370.55%-392.6M
17.71%196.1M
623.91%266.4M
27.92%-58.1M
150.10%127M
-81.43%30.9M
-18.53%166.6M
Depreciation and amortization
14.70%482.9M
11.86%126.4M
15.46%121.7M
17.07%120.7M
14.67%114.1M
23.32%421M
12.89%113M
13.82%105.4M
38.58%103.1M
33.92%99.5M
Deferred tax
9.61%-757.3M
2.13%-280.2M
-34.13%-168.6M
43.57%-118.1M
12.06%-190.4M
-12.25%-837.8M
-2.36%-286.3M
-46.67%-125.7M
-34.17%-209.3M
3.78%-216.5M
Other non cash items
36,200.00%36.1M
488.57%68M
-145.76%-29M
-134.88%-3M
-99.51%100K
-100.02%-100K
-110.36%-17.5M
-119.44%-11.8M
-96.55%8.6M
-75.56%20.6M
Change In working capital
-557.07%-618.3M
-40.72%-86.4M
66.77%-63.9M
-1,017.47%-908.5M
82.86%440.5M
61.32%-94.1M
-116.07%-61.4M
71.18%-192.3M
89.59%-81.3M
-70.74%240.9M
-Change in receivables
-63.52%-554M
-42.44%-117.8M
16.09%-388.9M
-18,200.00%-494.1M
112.66%446.8M
-147.87%-338.8M
-137.66%-82.7M
-19.80%-463.5M
99.16%-2.7M
-82.46%210.1M
-Change in inventory
-128.08%-619.7M
-148.84%-117.7M
-112.95%-164.4M
-81.08%-181.8M
-232.91%-155.8M
60.99%-271.7M
67.22%-47.3M
65.46%-77.2M
58.18%-100.4M
47.18%-46.8M
-Change in prepaid assets
-239.30%-407.5M
-133.66%-55.3M
191.47%252M
-15,379.41%-526.3M
-1,316.36%-77.9M
19.18%-120.1M
778.61%164.3M
-327.31%-275.5M
98.60%-3.4M
87.72%-5.5M
-Change in payables and accrued expense
22.80%735.1M
262.65%225.6M
-66.40%194.4M
415.37%204.6M
-7.14%110.5M
532.51%598.6M
-139.90%-138.7M
460.95%578.6M
152.72%39.7M
147.52%119M
-Change in other working capital
501.06%227.8M
-149.30%-21.2M
-5.08%43M
714.48%89.1M
425.63%116.9M
16.98%37.9M
172.15%43M
355.93%45.3M
-114.47%-14.5M
-477.89%-35.9M
Cash from discontinued investing activities
Operating cash flow
-3.78%4.42B
15.89%1.26B
15.88%1.29B
-65.38%354M
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
Investing cash flow
Cash flow from continuing investing activities
22.51%-2.47B
629.61%350.6M
-15.74%-574.4M
76.66%-557.2M
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
Capital expenditure reported
-5.19%-755.9M
20.60%-199.6M
-37.44%-241.9M
-59.73%-180.5M
24.86%-133.9M
-21.78%-718.6M
-65.18%-251.4M
-23.51%-176M
26.43%-113M
-25.67%-178.2M
Net PPE purchase and sale
--20.1M
--0
--0
----
----
--0
--0
--0
----
----
Net intangibles purchase and sale
39.51%-125.7M
-8.53%-67.4M
--0
-45.45%-30.4M
72.35%-27.9M
79.76%-207.8M
37.90%-62.1M
97.42%-23.9M
---20.9M
---100.9M
Net business purchase and sale
69.95%-16.5M
-202.63%-11.5M
--0
----
----
76.16%-54.9M
---3.8M
---51.1M
----
----
Net investment purchase and sale
27.85%-1.59B
150.54%629.1M
-35.55%-332.5M
83.96%-361.4M
-3,614.52%-1.53B
-13.75%-2.2B
115.64%251.1M
-119.44%-245.3M
-7,410.00%-2.25B
102.78%43.4M
Cash from discontinued investing activities
Investing cash flow
22.51%-2.47B
629.61%350.6M
-15.74%-574.4M
76.66%-557.2M
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
Financing cash flow
Cash flow from continuing financing activities
-22.93%-2.2B
-154.54%-1.14B
-55.66%-634M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
Net common stock issuance
-21.06%-2.17B
-154.54%-1.14B
-47.46%-600.6M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
Net other financing activities
---33.4M
--0
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-22.93%-2.2B
-154.54%-1.14B
-55.66%-634M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
Net cash flow
Beginning cash position
-12.23%2.74B
-6.87%2.01B
-1.10%1.93B
-33.57%2.61B
-12.23%2.74B
7.64%3.12B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
7.64%3.12B
Current changes in cash
34.92%-248.1M
-17.23%477.9M
-60.70%82.8M
65.57%-681.3M
-115.75%-127.5M
-272.25%-381.2M
249.82%577.4M
119.02%210.7M
-4,105.47%-1.98B
75.54%809.4M
Effect of exchange rate changes
-75.00%-700K
-450.00%-700K
500.00%800K
25.00%-300K
---500K
---400K
--200K
---200K
---400K
--0
End cash Position
-9.09%2.49B
-9.09%2.49B
-6.87%2.01B
-1.10%1.93B
-33.57%2.61B
-12.23%2.74B
-12.23%2.74B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
Free cash flow
-3.51%3.54B
28.29%995.8M
14.75%1.05B
-83.89%143.1M
24.09%1.35B
7.93%3.67B
-47.11%776.2M
307.63%914.4M
116.29%888.5M
-44.46%1.09B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.78%4.42B15.89%1.26B15.88%1.29B-65.38%354M10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B
Net income from continuing operations 11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M
Operating gains losses -144.41%-118.3M466.44%212.9M-206.06%-134.7M-1,370.55%-392.6M17.71%196.1M623.91%266.4M27.92%-58.1M150.10%127M-81.43%30.9M-18.53%166.6M
Depreciation and amortization 14.70%482.9M11.86%126.4M15.46%121.7M17.07%120.7M14.67%114.1M23.32%421M12.89%113M13.82%105.4M38.58%103.1M33.92%99.5M
Deferred tax 9.61%-757.3M2.13%-280.2M-34.13%-168.6M43.57%-118.1M12.06%-190.4M-12.25%-837.8M-2.36%-286.3M-46.67%-125.7M-34.17%-209.3M3.78%-216.5M
Other non cash items 36,200.00%36.1M488.57%68M-145.76%-29M-134.88%-3M-99.51%100K-100.02%-100K-110.36%-17.5M-119.44%-11.8M-96.55%8.6M-75.56%20.6M
Change In working capital -557.07%-618.3M-40.72%-86.4M66.77%-63.9M-1,017.47%-908.5M82.86%440.5M61.32%-94.1M-116.07%-61.4M71.18%-192.3M89.59%-81.3M-70.74%240.9M
-Change in receivables -63.52%-554M-42.44%-117.8M16.09%-388.9M-18,200.00%-494.1M112.66%446.8M-147.87%-338.8M-137.66%-82.7M-19.80%-463.5M99.16%-2.7M-82.46%210.1M
-Change in inventory -128.08%-619.7M-148.84%-117.7M-112.95%-164.4M-81.08%-181.8M-232.91%-155.8M60.99%-271.7M67.22%-47.3M65.46%-77.2M58.18%-100.4M47.18%-46.8M
-Change in prepaid assets -239.30%-407.5M-133.66%-55.3M191.47%252M-15,379.41%-526.3M-1,316.36%-77.9M19.18%-120.1M778.61%164.3M-327.31%-275.5M98.60%-3.4M87.72%-5.5M
-Change in payables and accrued expense 22.80%735.1M262.65%225.6M-66.40%194.4M415.37%204.6M-7.14%110.5M532.51%598.6M-139.90%-138.7M460.95%578.6M152.72%39.7M147.52%119M
-Change in other working capital 501.06%227.8M-149.30%-21.2M-5.08%43M714.48%89.1M425.63%116.9M16.98%37.9M172.15%43M355.93%45.3M-114.47%-14.5M-477.89%-35.9M
Cash from discontinued investing activities
Operating cash flow -3.78%4.42B15.89%1.26B15.88%1.29B-65.38%354M10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B
Investing cash flow
Cash flow from continuing investing activities 22.51%-2.47B629.61%350.6M-15.74%-574.4M76.66%-557.2M-615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M
Capital expenditure reported -5.19%-755.9M20.60%-199.6M-37.44%-241.9M-59.73%-180.5M24.86%-133.9M-21.78%-718.6M-65.18%-251.4M-23.51%-176M26.43%-113M-25.67%-178.2M
Net PPE purchase and sale --20.1M--0--0----------0--0--0--------
Net intangibles purchase and sale 39.51%-125.7M-8.53%-67.4M--0-45.45%-30.4M72.35%-27.9M79.76%-207.8M37.90%-62.1M97.42%-23.9M---20.9M---100.9M
Net business purchase and sale 69.95%-16.5M-202.63%-11.5M--0--------76.16%-54.9M---3.8M---51.1M--------
Net investment purchase and sale 27.85%-1.59B150.54%629.1M-35.55%-332.5M83.96%-361.4M-3,614.52%-1.53B-13.75%-2.2B115.64%251.1M-119.44%-245.3M-7,410.00%-2.25B102.78%43.4M
Cash from discontinued investing activities
Investing cash flow 22.51%-2.47B629.61%350.6M-15.74%-574.4M76.66%-557.2M-615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M
Financing cash flow
Cash flow from continuing financing activities -22.93%-2.2B-154.54%-1.14B-55.66%-634M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M
Net common stock issuance -21.06%-2.17B-154.54%-1.14B-47.46%-600.6M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M
Net other financing activities ---33.4M--0--------------------------------
Cash from discontinued financing activities
Financing cash flow -22.93%-2.2B-154.54%-1.14B-55.66%-634M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M
Net cash flow
Beginning cash position -12.23%2.74B-6.87%2.01B-1.10%1.93B-33.57%2.61B-12.23%2.74B7.64%3.12B-38.36%2.16B-42.80%1.95B16.96%3.93B7.64%3.12B
Current changes in cash 34.92%-248.1M-17.23%477.9M-60.70%82.8M65.57%-681.3M-115.75%-127.5M-272.25%-381.2M249.82%577.4M119.02%210.7M-4,105.47%-1.98B75.54%809.4M
Effect of exchange rate changes -75.00%-700K-450.00%-700K500.00%800K25.00%-300K---500K---400K--200K---200K---400K--0
End cash Position -9.09%2.49B-9.09%2.49B-6.87%2.01B-1.10%1.93B-33.57%2.61B-12.23%2.74B-12.23%2.74B-38.36%2.16B-42.80%1.95B16.96%3.93B
Free cash flow -3.51%3.54B28.29%995.8M14.75%1.05B-83.89%143.1M24.09%1.35B7.93%3.67B-47.11%776.2M307.63%914.4M116.29%888.5M-44.46%1.09B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.